REGN实时信号 | 通过Getagraph.com最大化利润

出售 41 min ago

@ $1 068.29

发出时间: 26 Jun 2024 @ 23:45

回报率: 0.48%

上一信号: Jun 25 - 23:32

上一信号: 购买

回报率: -0.56 %

Live Chart Being Loaded With Signals

Commentary (27 Jun 2024 @ 00:26):
Our systems believe the stock currently is undervalued by 0.87% compare to its pairs and should correct upwards.

Stats
今日成交量	199 894
平均成交量	449 941
市值	116.33B
EPS	$6.70 ( Q1 \| 2024-05-02 )
下一个收益日期	( $10.57 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	31.70 (Sector) 42.63 (Industry) 24.32
ATR14	$22.62 (2.11%)

AADI -3.24%

ABCL 2.01%

ABCM 0.04%

ABEO -2.14%

ABIO -1.68%

ABOS 0.70%

ABSI 1.53%

ABUS -1.97%

ABVX -1.50%

ACAD -0.64%

ACER -17.95%

ACET -4.76%

ACGN 1.29%

ACHL -4.11%

ACHV 0.00%

ACIU -0.75%

ACLX 0.79%

ACRV -2.31%

ACST -2.90%

ACXP 1.38%

ADAG 4.64%

ADAP -4.19%

ADGI 0.87%

ADIL 1.75%

ADMA -2.13%

ADPT 0.00%

ADTX -2.08%

ADVM -3.62%

ADXN -1.60%

AEON -5.61%

AEZS -2.49%

AFMD -2.94%

AGEN -2.72%

AGIO -2.39%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -0.18%

AKRO -3.27%

AKTX 1.05%

AKUS 0.00%

ALBO 0.00%

ALDX -2.10%

ALEC 0.46%

ALGS -0.74%

ALKS 0.52%

ALLK -9.75%

ALLO -6.46%

ALLR -0.77%

ALNA 3.16%

ALNY 2.43%

ALPN 0.02%

ALPX 0.00%

ALRN -1.33%

ALT -9.45%

ALVR 2.98%

ALXN 0.00%

ALXO -13.10%

ALZN 5.27%

AMRN -1.12%

AMTI -3.13%

ANAB 1.09%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX 0.00%

ANPC -3.15%

APGE -0.91%

APGN 8.48%

APGNW 30.65%

APLM -2.32%

APLS 0.50%

APLT -3.04%

APM 0.36%

APOP 0.38%

APRE 0.60%

APTO 5.98%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -4.59%

ARDS -14.23%

ARDX 0.17%

ARGX -0.90%

ARNA 0.00%

ARPO -0.90%

ARQT -0.37%

ARTL -2.50%

ARTLW 0.00%

ARVN 4.97%

ARWR -1.06%

ASLN -5.07%

ASMB -5.81%

ASND -1.79%

ATAI -1.85%

ATHA 5.39%

ATHE 0.56%

ATHX -33.50%

ATNF 4.32%

ATOS 0.97%

ATRA -3.05%

ATXI -2.78%

ATXS -0.11%

AUPH -0.99%

AURA 2.79%

AUTL -1.58%

AVBP -3.32%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -3.47%

AVTX -1.25%

AVXL -3.95%

AXLA 0.00%

AXSM -1.11%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 3.47%

BCAB 5.23%

BCDA -2.23%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.83%

BCRX 0.25%

BCTX 8.90%

BCTXW -16.32%

BCYC 0.75%

BDRX -4.64%

BDTX -1.81%

BEAM 1.07%

BFRA -2.91%

BGNE -2.40%

BIOR -5.21%

BIVI 3.41%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.78%

BLU 0.03%

BLUE -0.14%

BMEA -11.36%

BMRN 0.21%

BNOX 6.22%

BNTC -0.42%

BNTX -1.55%

BOLD -12.19%

BOLT -1.24%

BPMC -1.08%

BPTH 0.00%

BPTS -13.47%

BRNS 0.00%

BRTX -3.52%

BTAI 24.92%

BTTX 50.67%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 4.24%

CABA 1.59%

CADL -1.95%

CALA 0.00%

CALC -1.77%

CALT -1.59%

CAPR -1.72%

CARA -0.06%

CARM 13.05%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -5.22%

CCCC -5.84%

CCXI 0.00%

CDAK 0.00%

CDIO -2.25%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -7.72%

CDTTW -39.60%

CDTX -1.31%

CDXC 0.20%

CDXS 7.06%

CELC -4.37%

CELU -1.00%

CELUW 11.80%

CERC -1.68%

CERE -1.23%

CERO -3.45%

CEROW -21.56%

CFRX -27.95%

CGEM -3.16%

CGEN -3.05%

CGON -1.78%

CGTX -3.98%

CHMA -6.00%

CHRS 1.27%

CINC 0.00%

CING -0.63%

CINGW 34.95%

CKPT -3.35%

CLBS -16.75%

CLDX -1.33%

CLGN 0.34%

CLLS -4.15%

CLNN 1.92%

CLNNW 0.00%

CLRB 6.27%

CLSD 0.78%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 0.00%

CMPI 0.00%

CMPX -1.42%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.47%

CNCE 0.00%

CNSP -36.88%

CNST 0.00%

CNTA -0.45%

CNTB 0.00%

CNTX -7.32%

COCP -2.00%

COEPW 32.45%

COGT -2.16%

CORT 2.75%

COYA -1.46%

CPRX -0.99%

CRBP -3.74%

CRBU -5.97%

CRDF -1.32%

CRGX -0.13%

CRIS -1.72%

CRNX -5.86%

CRSP 0.48%

CRTX 2.63%

CRVO -5.75%

CRVS 1.69%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -3.72%

CTNM -3.21%

CTXR 2.43%

CUE 6.57%

CVAC -4.94%

CVKD -2.85%

CWBR 2.80%

CYAD -12.96%

CYCC 9.09%

CYCCP 5.49%

CYCN -0.24%

CYT -2.27%

CYTK -2.46%

CYTO -1.83%

DARE 4.16%

DAWN -1.12%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 30.53%

DNLI -1.52%

DNTH -9.93%

DOMH 2.43%

DRMA -1.68%

DRMAW -1.25%

DRNA 0.00%

DRTS 3.45%

DRTSW 0.00%

DRUG 0.95%

DSGN -2.72%

DTIL 1.99%

DYAI 12.26%

EARS -1.77%

EDIT -2.52%

EDSA 3.19%

EFTR 5.89%

EFTRW -51.85%

EIGR -9.21%

ELAB -2.84%

ELDN 8.99%

ELEV -5.81%

ELOX -5.38%

ELTX -0.88%

ELVN -3.87%

ELYM 2.23%

ENGN -1.72%

ENGNW 0.00%

ENLV 2.90%

ENOB 1.79%

ENSC 3.23%

ENTA 0.08%

ENTO -2.42%

ENTX 1.60%

ENVB 1.58%

EPIX -2.36%

EPRX -1.15%

EPZM 0.00%

EQ 0.34%

EQRX -2.09%

EQRXW 0.00%

ERAS -0.72%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -1.72%

ETON 2.13%

ETTX 0.00%

EVAX -2.14%

EVGN 4.76%

EVLO 0.00%

EWTX -0.40%

EXAI -1.32%

EXEL 0.04%

EYEG -0.69%

EYEN 1.42%

EYPT 0.61%

FATE -9.69%

FBIO 0.85%

FBIOP -0.37%

FBLG -15.00%

FBRX -0.02%

FDMT -3.50%

FENC -1.29%

FGEN -7.23%

FHTX 6.87%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.03%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.27%

FULC -3.68%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -5.36%

GANX -2.31%

GBIO -2.83%

GBT 0.01%

GDTC 0.50%

GERN -4.54%

GHRS -2.30%

GLMD -5.09%

GLPG -2.15%

GLSI 1.43%

GLTO -2.16%

GLUE -2.37%

GLYC -10.18%

GMAB -0.23%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -3.14%

GNLX 1.33%

GNPX 0.00%

GNTA 3.94%

GOSS -10.43%

GOVX 0.91%

GOVXW -49.04%

GPCR -8.66%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 1.31%

GRTX 5.14%

GTHX 0.23%

GUTS -5.08%

GXGXW 41.67%

GYRE -8.37%

HALO -1.05%

HARP 0.09%

HCWB -3.75%

HEPA -4.09%

HGEN -84.62%

HILS 5.66%

HLVX 0.00%

HOOK 2.83%

HOTH -3.51%

HOWL -2.35%

HRMY 1.73%

HRTX 3.77%

HSTO 0.00%

HUMA 0.71%

HUMAW -0.01%

IBRX -4.27%

ICCC 0.22%

ICPT 0.21%

ICU 17.39%

ICUCW 20.46%

ICVX -0.91%

IDRA -23.04%

IDYA -1.77%

IFRX -1.54%

IGMS -0.29%

IKNA 1.19%

IKT 0.70%

IMAB 2.03%

IMCR -2.96%

IMGN 0.02%

IMGO 0.00%

IMMP 4.75%

IMMX -7.76%

IMNM 1.04%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.35%

IMTX -0.75%

IMTXW 6.00%

IMUX 1.85%

IMV 0.00%

IMVT -5.02%

INAB -0.56%

INBX 0.76%

INCY -1.28%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 3.14%

INMB 1.68%

INO -1.37%

INSM -1.26%

INTS -2.75%

INVA 0.56%

INZY 0.69%

IOBT -11.02%

IONS 0.64%

IOVA -2.96%

IPA -0.49%

IPHA 5.58%

IPSC -2.34%

IRON -1.64%

ISEE 0.38%

ITOS -1.71%

ITRM 1.67%

IVA 6.96%

IVVD -2.48%

JAGX 0.79%

JANX -3.90%

JAZZ -0.45%

JNCE 0.00%

JSPR -5.85%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -5.02%

KDNY 0.22%

KMPH -0.34%

KNSA -2.06%

KNTE -0.38%

KOD -6.13%

KPRX 0.96%

KPTI -5.05%

KRBP -10.00%

KRON 0.58%

KROS -1.10%

KRRO -8.11%

KRTX 0.03%

KRYS -0.40%

KTRA 8.15%

KTTA -6.79%

KTTAW 0.92%

KURA -0.29%

KYMR -3.00%

KYTX -4.13%

KZIA 2.65%

KZR -0.60%

LABP 0.57%

LBPH -1.18%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.82%

LENZ -5.29%

LEXX 0.78%

LEXXW -14.63%

LGND -0.50%

LGNDV 0.00%

LGVN -7.47%

LIAN -8.28%

LIFE 2.70%

LIPO -3.87%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.04%

LPCN -1.86%

LPTX -1.92%

LQDA -0.16%

LRMR -1.56%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.03%

LXEO -2.79%

LXRX -2.06%

LYEL -35.91%

LYRA 1.16%

MACK 0.10%

MBIO -9.49%

MBRX -1.72%

MCRB 3.17%

MDGL -0.97%

MDNA -13.16%

MDWD -0.34%

MDXG -2.80%

MEIP 1.40%

MESO -1.41%

MGNX -2.80%

MGTA -7.74%

MGTX -3.68%

MGX -2.68%

MIRM -1.27%

MIRO 0.59%

MIST 1.15%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX 0.71%

MLYS -7.56%

MNKD 0.38%

MNMD -0.07%

MNOV 2.11%

MNPR -8.52%

MOLN 1.79%

MOR 1.20%

MORF -3.40%

MREO -3.29%

MRKR 2.57%

MRNA -5.84%

MRNS -4.04%

MRSN -2.38%

MRTX -0.17%

MRUS 0.37%

MRVI -1.46%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.08%

MYMD 5.46%

NAMS 2.75%

NAMSW -0.21%

NAUT 1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 12.09%

NCNA 0.73%

NERV -0.63%

NEXI 4.04%

NGM -1.28%

NGNE -1.87%

NKGN 9.46%

NKGNW 8.00%

NKTR -4.21%

NKTX -5.38%

NLSP 5.35%

NLSPW 26.67%

NMRA -3.08%

NMTR -42.97%

NOVN -24.84%

NRBO 10.32%

NRIX -2.12%

NRSN -5.12%

NRSNW 0.00%

NRXP -4.58%

NRXPW 18.33%

NRXS 4.82%

NTBL 3.42%

NTEC -12.45%

NTHI 0.00%

NTLA -7.13%

NTRBW -31.07%

NUVL -1.69%

NVAX -2.50%

NVCT 3.55%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 1.58%

OABIW -10.06%

OBIO -3.07%

OBSV 0.00%

OCEA 0.00%

OCGN 2.97%

OCS -1.00%

OCUL -0.08%

OCUP 1.84%

ODT -4.27%

OKYO 1.51%

OLMA -5.29%

OMER -1.03%

OMGA 5.41%

ONCO 4.54%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY 1.49%

ONTX -0.47%

ONVO 0.47%

OPNT 0.00%

OPT 3.09%

ORGS 0.96%

ORIC -3.49%

ORMP 17.41%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.22%

OVID 0.61%

OYST 0.00%

PALI 1.30%

PASG -1.30%

PBLA -7.50%

PBM -4.84%

PBYI 1.52%

PCSA 0.00%

PCVX -0.30%

PDSB -4.59%

PEPG 0.09%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -0.83%

PHIOW 36.47%

PHVS -7.32%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.47%

PLUR 7.39%

PMN 0.72%

PMVP -0.30%

PNT 0.16%

PPBT -5.61%

PRAX 3.19%

PRDS 0.93%

PRLD -2.37%

PROG -3.47%

PROK 0.00%

PRQR -0.66%

PRTA -2.70%

PRTC 0.49%

PRTG 7.02%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -10.37%

PSTX -1.94%

PTCT -0.51%

PTE -0.82%

PTGX -0.91%

PTIXW -48.41%

PULM 2.60%

PXMD 4.76%

PYPD 0.07%

PYXS 1.14%

QLGN -3.00%

QNCX 5.70%

QNRX -1.34%

QSI -11.54%

QSIAW -3.13%

QTTB -3.42%

QURE -0.79%

RAIN -1.63%

RANI 6.42%

RAPT -1.26%

RARE 1.27%

RCKT -8.81%

REGN 0.21%

RENB -3.11%

REPL -2.27%

RETA 0.02%

REUN -0.89%

REVB -2.79%

REVBU 3.46%

REVBW 4.38%

RGLS -6.54%

RGNX -5.56%

RIGL -3.28%

RLAY -3.56%

RLMD 0.35%

RLYB -1.01%

RNA 0.62%

RNAC -2.94%

RNAZ -1.90%

RNXT 0.89%

ROIV -2.08%

ROIVW 4.56%

RPHM 0.00%

RPRX 0.33%

RPTX 0.15%

RUBY 2.70%

RVLP -32.05%

RVMD -0.98%

RVMDW -30.00%

RVNC 0.21%

RVPH -2.38%

RVPHW 1.62%

RXDX 0.09%

RXRX -4.96%

RYTM -5.05%

RYZB 0.02%

RZLT 3.93%

SABS -1.37%

SABSW -11.81%

SAGE 1.19%

SANA -3.69%

SAVA -0.16%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -0.06%

SCPH 5.32%

SCPS 0.00%

SEEL -4.12%

SEER 0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.30%

SGMT -2.60%

SGTX -2.56%

SIOX 22.63%

SLDB -9.57%

SLGL 4.12%

SLN -4.57%

SLNO -4.39%

SLRX 5.26%

SLS -1.71%

SMMT -1.62%

SNDX 1.28%

SNGX -4.91%

SNPX -4.44%

SONN -0.01%

SPPI -0.49%

SPRB 0.63%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -1.11%

SRRA 0.00%

SRRK -1.98%

SRZN -2.45%

STAB 0.00%

STOK -5.66%

STRO -4.01%

STSA 0.00%

STTK -1.69%

SURF -0.93%

SVRA -8.03%

SWTX -0.44%

SYBX -1.29%

SYRS -1.55%

TALS -0.73%

TARA -7.14%

TARS 0.45%

TBPH 0.60%

TCBP 2.48%

TCDA 0.00%

TCON 2.46%

TCRR 0.00%

TCRT 0.08%

TCRX -1.05%

TECH -0.21%

TENX 1.91%

TERN -8.21%

TFFP -5.33%

TGTX -4.39%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -4.60%

TNGX -3.13%

TNXP -6.00%

TNYA -5.08%

TPST 4.85%

TRDA -4.06%

TRVI 2.30%

TRVN 6.50%

TSHA -22.87%

TSVT -2.93%

TTNP -7.66%

TVTX 1.26%

TYRA -8.54%

UBX -2.48%

UNCY -4.00%

URGN -1.15%

UTHR 0.57%

VACC 11.36%

VALN -4.07%

VAXX 116.88%

VBIV 0.31%

VBLT -8.77%

VCEL 0.74%

VCNX 10.35%

VCYT -1.67%

VERA -3.92%

VERU 0.98%

VERV -3.06%

VIGL 4.84%

VINC 2.28%

VIR 1.08%

VIRI -1.85%

VIRX 3.26%

VKTX -1.36%

VLON -13.04%

VNDA -3.58%

VOR -2.02%

VRCA -0.28%

VRDN -4.55%

VRNA -0.80%

VRPX 0.38%

VRTX 0.36%

VSTM -1.19%

VTGN -0.91%

VTVT -2.97%

VTYX -0.84%

VXRT -4.09%

VYGR -0.38%

VYNE -4.62%

VYNT 7.78%

WINT 2.18%

WVE -6.39%

XBIO 1.03%

XBIT -2.92%

XCUR 3.55%

XENE -1.38%

XERS 2.62%

XFOR 4.69%

XLO 2.19%

XLRN 0.00%

XNCR 0.52%

XOMA -2.53%

XOMAO -0.16%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.73%

ZNTL -2.38%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-24	Bassler Bonnie L	Sell	756	Non-Qualified Stock Option (right to buy)
2024-06-24	Bassler Bonnie L	Buy	756	Common Stock
2024-06-24	Bassler Bonnie L	Sell	756	Common Stock
2024-06-24	Larosa Joseph J	Buy	14 450	Common Stock
2024-06-24	Larosa Joseph J	Sell	11 084	Common Stock

INSIDER POWER
-42.51
Last 100 transactions
Buy: 261 982 \| Sell: 649 170

相关性 (AI algo v.1.1b): Undervalued: 0.87% $1 082.83 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

音量相关性

長: 0.74 (moderate)

短: 0.61 (weak)

Signal:(66) Neutral

Regeneron Pharmaceuticals 相关性

10 最正相关
KPLT	0.823

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Regeneron Pharmaceuticals 相关性 - 货币/商品

0.48
( neutral )

-0.30
( neutral )

0.82
( strong )

0.36
( neutral )

-0.29
( neutral )

-0.77
( moderate negative )

Regeneron Pharmaceuticals 财务报表

Annual	2023
营收:	$13.12B
毛利润:	$11.30B (86.16 %)
EPS:	$37.05

FY	2023
营收:	$13.12B
毛利润:	$11.30B (86.16 %)
EPS:	$37.05

FY	2022
营收:	$12.17B
毛利润:	$10.61B (87.18 %)
EPS:	$40.51

FY	2021
营收:	$16.07B
毛利润:	$13.63B (84.83 %)
EPS:	$76.40

Financial Reports:

Symbol	Period	Year	Title
REGN	Q4	2023	Financial Report for REGN - Q4 2023

Regeneron Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma;Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.